NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
68,35 USD
arrow_downward
-0,35%(-0,24) 1D
16-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
68,34 USD
High
68,72 USD
Low
68,00 USD
Mkt. cap
183,47 млд
Avg. vol.
23,36 миң
Volume
17,43 миң
52-wk high
75,26 USD
52-wk low
49,90 USD
Beta
0,87
Shares outstanding
414,56 млн
No. of employees
11 миң
Open
68,34 USD
High
68,72 USD
Low
68,00 USD
Mkt. cap
183,47 млд
Avg. vol.
23,36 миң
Volume
17,43 миң
52-wk high
75,26 USD
52-wk low
49,90 USD
Beta
0,87
Shares outstanding
414,56 млн
No. of employees
11 миң
News stories
From web sources and news partners
GlobeNewswire
·
22 мүнөт мурун
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock Titan
·
22 мүнөт мурун
Viewers will be able to question AI panelists live from Nasdaq on Oct. 20
Dallas Express
·
46 мүнөт мурун
Two Texas Companies Leave Nasdaq For Dallas-Based TXSE
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
CEOEster Baiget
Employees11,1 миң
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com